US EditionAIM movers: Facilities by ADF hit by film tariff fears and Aptamer royalty deal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
AIM movers: Facilities by ADF hit by film tariff fears and Aptamer royalty deal
In content advertising company Mirriad Advertising (LON: MIRI) has clawed back some of last week’s share price fall after it said it was running out of money and the business may have to be placed into administration. There has been no positive update since then, but the share price rebounded 8.33% to 0.0325p. Kefi Gold […] The post AIM movers: Facilities by ADF hit by film tariff fears and Aptamer royalty deal appeared first on UK Investor Maga…
York’s Aptamer says Alzheimer’s test advances – Northern Financial Review
York-based Aptamer Group plc, the developer of next-generation synthetic binders for the life science industry, announced “the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA), a format widely accepted and used in hospital laboratories.” Aptamer said it has also finalised a royalty agreement with its development partner, Neuro-Bio Ltd. Under the agreed terms, Aptamer is eli…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
